Sökning: WFRF:(Juliusson Gunnar) >
Dendritic cell vacc...
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
-
- Anguille, Sébastien (författare)
- University of Antwerp,Antwerp University Hospital
-
- Van De Velde, Ann L. (författare)
- University of Antwerp,Antwerp University Hospital
-
- Smits, Evelien L. (författare)
- University of Antwerp
-
visa fler...
-
- Van Tendeloo, Viggo F. (författare)
- University of Antwerp
-
- Juliusson, Gunnar (författare)
- Lund University,Lunds universitet,Skåne University Hospital
-
- Cools, Nathalie (författare)
- University of Antwerp
-
- Nijs, Griet (författare)
- University of Antwerp,Antwerp University Hospital
-
- Stein, Barbara (författare)
- Antwerp University Hospital,University of Antwerp
-
- Lion, Eva (författare)
- University of Antwerp
-
- Driessche, Ann Van (författare)
- University of Antwerp,Antwerp University Hospital
-
- Vandenbosch, Irma (författare)
- Antwerp University Hospital
-
- Verlinden, Anke (författare)
- Antwerp University Hospital,University of Antwerp
-
- Gadisseur, Alain P. (författare)
- Antwerp University Hospital,University of Antwerp
-
- Schroyens, Wilfried A. (författare)
- Antwerp University Hospital,University of Antwerp
-
- Muylle, Ludo (författare)
- University of Antwerp,Antwerp University Hospital
-
- Vermeulen, Katrien (författare)
- Antwerp University Hospital
-
- Maes, Marie Berthe (författare)
- Antwerp University Hospital
-
- Deiteren, Kathleen (författare)
- Antwerp University Hospital
-
- Malfait, Ronald (författare)
- Antwerp University Hospital
-
- Gostick, Emma (författare)
- Cardiff University
-
- Lammens, Martin (författare)
- Antwerp University Hospital
-
- Couttenye, Marie M. (författare)
- Antwerp University Hospital
-
- Jorens, Philippe (författare)
- Antwerp University Hospital
-
- Goossens, Herman (författare)
- University of Antwerp,Antwerp University Hospital
-
- Price, David A. (författare)
- Cardiff University
-
- Ladell, Kristin (författare)
- Cardiff University
-
- Oka, Yoshihiro (författare)
- Osaka University
-
- Fujiki, Fumihiro (författare)
- Osaka University
-
- Oji, Yusuke (författare)
- Osaka University
-
- Sugiyama, Haruo (författare)
- Osaka University
-
- Berneman, Zwi N. (författare)
- University of Antwerp,Antwerp University Hospital
-
visa färre...
-
(creator_code:org_t)
- American Society of Hematology, 2017
- 2017
- Engelska 9 s.
-
Ingår i: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 130:15, s. 1713-1721
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://ashpublicati...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Relapse is a major problem in acute myeloid leukemia (AML) and adversely affects survival. In this phase 2 study, we investigated the effect of vaccination with dendritic cells (DCs) electroporated with Wilms’ tumor 1 (WT1) messenger RNA (mRNA) as postremission treatment in 30 patients with AML at very high risk of relapse. There was a demonstrable antileukemic response in 13 patients. Nine patients achieved molecular remission as demonstrated by normalization of WT1 transcript levels, 5 of which were sustained after a median follow-up of 109.4 months. Disease stabilization was achieved in 4 other patients. Five-year overall survival (OS) was higher in responders than in nonresponders (53.8% vs 25.0%; P 5 .01). In patients receiving DCs in first complete remission (CR1), there was a vaccine-induced relapse reduction rate of 25%, and 5-year relapse-free survival was higher in responders than in nonresponders (50% vs 7.7%; P < .0001). In patients age £65 and >65 years who received DCs in CR1, 5-year OS was 69.2% and 30.8% respectively, as compared with 51.7% and 18% in the Swedish Acute Leukemia Registry. Long-term clinical response was correlated with increased circulating frequencies of polyepitope WT1-specific CD81 T cells. Long-term OS was correlated with interferon-g1 and tumor necrosis factor-a1 WT1-specific responses in delayed-type hypersensitivity-infiltrating CD81 T lymphocytes. In conclusion, vaccination of patients with AML with WT1 mRNA-electroporated DCs can be an effective strategy to prevent or delay relapse after standard chemotherapy, translating into improved OS rates, which are correlated with the induction of WT1-specific CD81 T-cell response. This trial was registered at www.clinicaltrials.gov as #NCT00965224.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
-
Blood
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Anguille, Sébast ...
-
Van De Velde, An ...
-
Smits, Evelien L ...
-
Van Tendeloo, Vi ...
-
Juliusson, Gunna ...
-
Cools, Nathalie
-
visa fler...
-
Nijs, Griet
-
Stein, Barbara
-
Lion, Eva
-
Driessche, Ann V ...
-
Vandenbosch, Irm ...
-
Verlinden, Anke
-
Gadisseur, Alain ...
-
Schroyens, Wilfr ...
-
Muylle, Ludo
-
Vermeulen, Katri ...
-
Maes, Marie Bert ...
-
Deiteren, Kathle ...
-
Malfait, Ronald
-
Gostick, Emma
-
Lammens, Martin
-
Couttenye, Marie ...
-
Jorens, Philippe
-
Goossens, Herman
-
Price, David A.
-
Ladell, Kristin
-
Oka, Yoshihiro
-
Fujiki, Fumihiro
-
Oji, Yusuke
-
Sugiyama, Haruo
-
Berneman, Zwi N.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Blood
- Av lärosätet
-
Lunds universitet